Insider · CIK 0001959250
Jonathan H Kaufman
Files at LIPO (LIPELLA PHARMACEUTICALS INC.). First filing Mar 19, 2024, latest May 15, 2024.
In brief
Jonathan H Kaufman files SEC Form 4 as officer, director and 10% owner at LIPO (LIPELLA PHARMACEUTICALS INC.). Since Mar 19, 2024, Jonathan H Kaufman has reported 2 open-market buys worth $53k and 0 open-market sells worth $0, the latest filed on May 15, 2024.
A track record needs three past buys with six months of prices behind them; Jonathan H Kaufman has 0, so none is measured yet.
The newest scored trade: bought $7,590 of LIPO on May 14, 2024, filed May 15, 2024, scored 20 (weak).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
LIPO: LIPELLA PHARMACEUTICALS INC.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 20Weak | LIPObuy LIPELLA PHARMACEUTICALS INC. | $7,590 10,000 shares | +1% | - | |
| 24Weak | LIPObuy LIPELLA PHARMACEUTICALS INC. | $45k 55,000 shares | +7% | - |
Transactions
Every row this insider has filed, 22 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 3, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | -536,959 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | -125,833 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | -28,924 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Apr 3, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | -4,060 | $0.00 | $0 | 0 | Apr 7, 2025 |
| Mar 13, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | +10,326 | $0.00 | $0 | 536,959 | Mar 17, 2025 |
| Mar 13, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | +4,060 | $0.00 | $0 | 4,060 | Mar 17, 2025 |
| Mar 10, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below)( | +84,700 | $0.00 | $0 | 526,633 | Mar 11, 2025 |
| Mar 10, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | +28,924 | $0.00 | $0 | 28,924 | Mar 11, 2025 |
| Feb 28, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | +441,933 | $0.00 | $0 | 441,933 | Mar 3, 2025 |
| Feb 28, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate | +125,833 | $0.00 | $0 | 125,833 | Mar 3, 2025 |
| Jan 15, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | -303,041 | $0.00 | $0 | 0 | Jan 17, 2025 |
| Jan 15, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | -85,421 | $0.00 | $0 | 0 | Jan 17, 2025 |
| Jan 15, 2025 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | -11,795 | $0.00 | $0 | 0 | Jan 17, 2025 |
| Dec 31, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan and an Affiliate (each as defined below) | +42,933 | $0.00 | $0 | 303,041 | Jan 3, 2025 |
| Dec 31, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | +11,795 | $0.00 | $0 | 11,795 | Jan 3, 2025 |
| Dec 23, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Series C Voting Convertible Preferred Stockderivativeindirect: By Self as proxy and power of attorney for Spartan (as defined below) | +260,108 | $0.00 | $0 | 260,108 | Dec 27, 2024 |
| Dec 23, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | JOther Common Stock Purchase Warrantsderivativeindirect: By Self as proxy and power of attorney for Spartan | +85,421 | $0.00 | $0 | 85,421 | Dec 27, 2024 |
| May 14, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | POpen-market purchase Common Stock | +10,000 | $0.76 | $7,590 | 898,849 | May 15, 2024 |
| Mar 18, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | POpen-market purchase Common Stock | +30,000 | $0.79 | $24k | 863,849 | Mar 19, 2024 |
| Mar 19, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | POpen-market purchase Common Stock | +25,000 | $0.87 | $22k | 888,849 | Mar 19, 2024 |
| Mar 15, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | AGrant or award Stock Optionsderivative | +80,000 | $0.00 | $0 | 80,000 | Mar 19, 2024 |
| Mar 13, 2024 | LIPO LIPELLA PHARMACEUTICALS INC. | AGrant or award Common Stock | +144,906 | $0.69 | $100k | 833,849 | Mar 15, 2024 |
Questions about Jonathan H Kaufman
Answered from the filings on this page, as of the latest one.
Is Jonathan H Kaufman buying or selling?
Not in the last 12 months. Jonathan H Kaufman's latest open-market trade on SEC Form 4 was bought $7,590 of LIPO on May 14, 2024.
How did Jonathan H Kaufman's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Jonathan H Kaufman has 0.
Where does Jonathan H Kaufman file Form 4?
Jonathan H Kaufman has filed Form 4 at LIPO (LIPELLA PHARMACEUTICALS INC.) as See remarks below.. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.